NIOX Group PLC

NIOX

Company Profile

  • Business description

    NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.

  • Contact

    1 Robert Robinson Avenue
    The Magdalen Centre
    The Oxford Science Park
    OxfordOX4 4GA
    GBR

    T: +44 3303309356

    E: [email protected]

    https://www.niox.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    84

Stocks News & Analysis

stocks

Chart of the Week: Opportunities with wide-moat retailers

Consumer defensive names look undervalued.
stocks

New ASX share added to our best ideas

Earnings outlook is strong and the shares trade at a discount to our fair value.
stocks

Fair value downgraded for ASX heavyweight

Our capital allocation rating was also lowered due to balance sheet weakness.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,136.6015.100.17%
CAC 407,966.9571.010.90%
DAX 4024,113.62232.900.98%
Dow JONES (US)46,441.1043.210.09%
FTSE 1009,446.4396.001.03%
HKSE26,855.56232.680.87%
NASDAQ22,755.1695.150.42%
Nikkei 22544,550.85381.78-0.85%
NZX 50 Index13,416.9617.03-0.13%
S&P 5006,711.2022.740.34%
S&P/ASX 2008,845.7012.300.14%
SSE Composite Index3,882.7820.250.52%

Market Movers